Figure 1
From: Microbiota-derived Trimethylamine N-oxide Predicts Cardiovascular Risk After STEMI
The distribution of TMAO and change after secondary prevention therapies. (A) The distribution of TMAO levels at the onset of STEMI and 10 months later. (B) Change in TMAO levels between the acute and chronic phases. IQR: interquartile range; STEMI: ST-segment elevation acute myocardial infarction; TMAO: trimethylamine N-oxide.
